That said, there are biologically plausible indirect pathways by which semaglutide treatmentespecially when accompanied by rapid appetite suppression, gastrointestinal adverse effects, and clinically meaningful weight losscould unmask or exacerbate pre-existing vaginal symptoms (for example, genitourinary syndrome of menopause) or contribute to discomfort through dehydration, altered sex steroid milieu, or pelvic soft-tissue volume changes
Weight loss results come from different studies with different groups of people and time frames
After working with Jodi DeVries, MS, APRN, CRNA at the Institute of Eternal Youth Aesthetics & Wellness in Winter Haven, he uncovered key hormonal imbalances and vitamin deficiencies
The effect of GLP-1 receptor agonists on circulating inflammatory markers in type 2 diabetes patients: A systematic review and meta-analysis Zhu, Kai, et al (2023) Efficacy and safety of semaglutide in non-alcoholic fatty liver disease Gastalldeli, Amalia, et al
Significant weight reduction is linked with a prolonged duration of about 6 to 15 years
.png)
